GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (OTCPK:BOIRF) » Definitions » Days Sales Outstanding

Boiron (Boiron) Days Sales Outstanding : 59.22 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Boiron Days Sales Outstanding?

Boiron's average Accounts Receivable for the six months ended in Dec. 2023 was $89.7 Mil. Boiron's Revenue for the six months ended in Dec. 2023 was $276.3 Mil. Hence, Boiron's Days Sales Outstanding for the six months ended in Dec. 2023 was 59.22.

The historical rank and industry rank for Boiron's Days Sales Outstanding or its related term are showing as below:

BOIRF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 59.82   Med: 67.61   Max: 74.68
Current: 65.48

During the past 13 years, Boiron's highest Days Sales Outstanding was 74.68. The lowest was 59.82. And the median was 67.61.

BOIRF's Days Sales Outstanding is ranked better than
55.91% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.69 vs BOIRF: 65.48

Boiron's Days Sales Outstanding increased from Dec. 2022 (59.18) to Dec. 2023 (59.22).


Boiron Days Sales Outstanding Historical Data

The historical data trend for Boiron's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron Days Sales Outstanding Chart

Boiron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.42 65.44 77.41 69.81 68.31

Boiron Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.12 65.26 59.18 67.05 59.22

Competitive Comparison of Boiron's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Boiron's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boiron's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Boiron's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Boiron's Days Sales Outstanding falls into.



Boiron Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Boiron's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (106.5 + 94.824) / 2 ) / 537.893*365
=100.662 / 537.893*365
=68.31

Boiron's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (84.478 + 94.824) / 2 ) / 276.296*365 / 2
=89.651 / 276.296*365 / 2
=59.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boiron  (OTCPK:BOIRF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Boiron Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Boiron's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Boiron (Boiron) Business Description

Traded in Other Exchanges
Address
2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Boiron (Boiron) Headlines

From GuruFocus

The Fastest Share Repurchasing Companies in Europe

By Holly LaFon Holly LaFon 07-04-2014